Tempus AI, Inc.TEMEarnings & Financial Report
Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."
Revenue
$166.0M
Gross Profit
N/A
Operating Profit
$-533.5M
Net Profit
$-552.2M
Gross Margin
N/A
Operating Margin
-321.4%
Net Margin
-332.7%
YoY Growth
25.3%
EPS
$-6.86
Financial Flow
Tempus AI, Inc. Q2 2024 Financial Summary
Tempus AI, Inc. reported revenue of $166.0M (up 25.3% YoY) for Q2 2024, with a net profit of $-552.2M (down 889.1% YoY) (-332.7% margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $166.0M |
|---|---|
| Net Profit | $-552.2M |
| Gross Margin | N/A |
| Operating Margin | -321.4% |
| Report Period | Q2 2024 |
Tempus AI, Inc. Annual Revenue by Year
Tempus AI, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.3B).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.3B |
| 2024 | $693.4M |
Tempus AI, Inc. Quarterly Revenue & Net Profit History
Tempus AI, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $367.2M | +83.0% | $-54.2M | -14.8% |
| Q3 2025 | $334.2M | +84.7% | $-80.0M | -23.9% |
| Q2 2025 | $314.6M | +89.6% | $-42.8M | -13.6% |
| Q1 2025 | $255.7M | +75.4% | $-68.0M | -26.6% |
| Q4 2024 | $200.7M | — | $-13.0M | -6.5% |
| Q3 2024 | $180.9M | +33.0% | $-75.8M | -41.9% |
| Q2 2024 | $166.0M | +25.3% | $-552.2M | -332.7% |
| Q1 2024 | $145.8M | — | $-64.7M | -44.4% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $145.8M | $166.0M | $180.9M | $200.7M | $255.7M | $314.6M | $334.2M | $367.2M |
| YoY Growth | N/A | 25.3% | 33.0% | N/A | 75.4% | 89.6% | 84.7% | 83.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | N/A | $864.6M | $971.7M | $926.1M | $1.54B | $1.63B | $2.28B | $2.27B |
| Liabilities | N/A | $766.4M | $918.0M | $869.8M | $1.22B | $1.32B | $1.77B | $1.78B |
| Equity | $-1.47B | $98.3M | $53.7M | $56.3M | $326.2M | $309.6M | $507.8M | $491.3M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $-101.4M | $-97.1M | $48.7M | $-105.6M | $44.2M | $-119.8M | $-36.8M |